Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee recommends orphan drug designation for MK-0677

May 25, 2017

FDA and EMA accept submissions for UX-003 for mucopolysaccharidosis VII

May 24, 2017

EMA grants orphan drug designation to avacopan for C3 glomerulopathy

May 24, 2017

EMA committee recommends approval of Oxervate for neurotrophic keratitis

May 23, 2017

EMA committee gives positive opinion to brodalumab for plaque psoriasis

May 23, 2017

Cariprazine granted positive opinion in Europe for the treatment of schizophrenia

May 23, 2017

Cardioxane receives positive CHMP opinion in Europe

May 22, 2017

Articular cartilage product granted positive opinion from CHMP for European approval

May 22, 2017

Chiesi's triple combination for the treatment of COPD receives positive opinion from EMA

May 22, 2017

EMA accepts for review MAA for adalimumab biosimilar, FKB-327

May 22, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...